ESTeSL - Artigos
Permanent URI for this collection
Browse
Browsing ESTeSL - Artigos by Subject "18F-FDG PET/CT"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Anxiety experienced by oncological patients who undergo 18F-FDG PET CT: a systematic reviewPublication . Vieira, Lina Oliveira; Pires, A.; Grilo, Ana MonteiroIntroduction: Anxiety is an emotional reaction often experienced by patients who undergo Positron Emission Tomography/Computed Tomography (PET/CT) with 18F-2-fluoro-2-deoxy-d-glucose (18F-FDG). This systematic review aimed to summarise the evidence currently available considering the anxiety experienced by adult oncological patients concerning pre and post 18F-FDG PET/CT examination and the factors contributing to anxiety. Methods: A systematic review search of CINAHL, PsycINFO, PubMed, Scopus, and Web Science databases and other manual search sources, was conducted from November to February 2021. The research included articles published from January 2000 to December 2020. It included quantitative studies, which analyzed the anxiety experienced by oncological patients who had undergone 18F-FDG PET/CT. Results: Ten articles met the inclusion criteria for this systematic review. The studies selected were published between 2011 and 2020 and carried out in five countries. Anxiety experienced by patients was evaluated at the various stages of the 18F-FDG PET/CT, eight studies assessed it in the pre-examination, seven studies in the post-examination, and five studies at both times. Four main anxiety factors were found: patients' clinical situation, first-time patients’ examination, scan procedure, and patients' concern with the examination result. Conclusion: Moderate to high levels of anxiety are present in most of the patients who undergo the examination. This review also highlights several factors related to the anxiety levels through different procedure moments. Implications for practice: The results of this research will allow health professionals to adjust non-pharmacological strategies to decrease anxiety levels in oncological patients undergoing 18F-FDG PET/CT.
- Anxiety in cancer patients during 18F-FDG PET/CT low dose: a comparison of anxiety levels before and after imaging studiesPublication . Grilo, Ana Monteiro; Vieira, Lina; Carolino, Elisabete; Oliveira, Cátia; Pacheco, Carolina; Castro, Maria; Alonso, JuanObjective - Assessing the level of anxiety in oncology patients who underwent (18)F-FDG PET/CT low dose scan and identifying the main reasons that generate anxiety. Material and Method - The study included 81 cancer patients submitted to the (18)F-FDG PET/CT low dose scan. Patients filled in the Scan Experience Questionnaire and the State-Trait Anxiety Inventory (STAI) before and after (18)F-FDG PET/CT low dose scan. Results - Substantial levels of anxiety were detected both before and after (18)F-FDG PET/CT low dose scan (STAI mean > 30), with a significant increase in the state of anxiety after scan performance (p < 0.0001, Medianpre = 31.1, and Medianpos = 33.0). (18)F-FDG PET/CT low dose results are the main cause of anxiety both before (79.1%) and after (86.9%) the scan. The information provided by staff both before and on the (18)F-FDG PET/CT low dose day was classified mostly as completely understandable (70.5% and 75.3%, resp.) and as very useful (70.5% and 72.6%, resp.) and correlated positively with patients' overall satisfaction with NM Department (rS = 0.372, p = 0.004 and rS = 0.528, p = 0.000, resp.), but not with anxiety levels. Conclusions - Patients perceive high levels of anxiety during the (18)F-FDG PET/CT low dose scan and the concern with scan results was pointed out as the main factor for that emotional reaction.